Development of systemic therapies to improve response and prevent resistance in the treatment of Melanoma [ 2017 - 2021 ]

Research Grant

Researchers: Prof Georgina Long (Principal investigator)

Brief description This program of research utilises the unique resources at Melanoma Institute Australia (MIA) to understand the biology of prolonged response and resistance to novel drug therapies used in metastatic melanoma, a cancer that now leads the field in the discovery of new targets for therapeutic manipulation. This program also aims to create new methods to efficiently test and develop drug therapy combinations in humans to improve patient outcomes further or prevent metastatic melanoma altogether.

Funding Amount $AUD 583,652.57

Funding Scheme Practitioner Fellowships

Notes Practitioner Fellowship